Start-Up Spotlight: Protaryx Aims To Simplify Transseptal Access
The company formed by ex-Edwards Lifesciences exec and Harpoon Medical founder raised $8m in Series A for universal catheter system for delivering beating heart treatments.
You may also be interested in...
Approval for Boston Scientific’s TheraSphere offers further access to the therapy that, until now, has only been available under a humanitarian device exemption.
The UK-based company is seeking to raise a further $100m in 2021 following the recent US clearance of its first product, a daytime-use neurostimulation device for snoring and mild obstructive sleep apnea.
The deal combines two of the largest providers of sterilization and infection-prevention products to create a $4bn-plus-revenue business.